Section Arrow
Quote
AMPH.NASDAQ
- Amphastar Pharmaceuticals
Quotes are at least 15-min delayed:2025/05/10 07:08 EDT
Last
 24.11
-0.54 (-2.19%)
Day High 
25.025 
Prev. Close
24.65 
1-M High
25.51 
Volume 
790.22K 
Bid
23.1
Ask
25.79
Day Low
23.3 
Open
24.54 
1-M Low
22.64 
Market Cap 
1.17B 
Currency USD 
P/E 8.06 
%Yield -- 
10-SMA 24.4 
20-SMA 24.05 
50-SMA 26.21 
52-W High 53.955 
52-W Low 22.64 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
3.06/--
Enterprise Value
1.81B
Balance Sheet
Book Value Per Share
15.42
Cash Flow
Cash Flow Yield
0.17
Income Statement
Total Revenue
731.97M
Operating Revenue Per Share
12.66
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SHPHShuttle Pharmaceuticals Holdings Inc0.2325-0.0375-13.89%-- 
PTPIPetros Pharmaceuticals Inc0.1201-0.0053-4.23%-- 
VTRSViatris8.77-0.32-3.52%227.2PE
TEVATeva Pharmaceutical Industries Limited16.93-1.14-6.31%-- 
IXHLIncannex Healthcare0.1135+0.0009+0.80%-- 
Quotes are at least 15-min delayed：2025/05/10 07:08 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulinactive pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.